ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,984Medicare Part D Prescriptions Filled, Including Refills

Rank: 174 out of 676

$562K Total Retail Price of All Prescriptions

Rank: 194 out of 676

473 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 473 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

20% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 9,367 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
HYDROCODONE-ACETAMINOPHEN 471 275 S3 1 1
FUROSEMIDE 422 309 2 4
AMLODIPINE BESYLATE 420 335 3 3
OMEPRAZOLE 392 299 4 2
POTASSIUM CHLORIDE 315 263 5 9
LISINOPRIL 309 232 6 5
DONEPEZIL HCL 300 300 7 24
LEVOTHYROXINE SODIUM 250 235 8 7
METFORMIN HCL 244 165 9 8
NAMENDA 226 226 10 35
DEXAMETHASONE 226 168 10 270
HYDROCHLOROTHIAZIDE 197 176 12 12
WARFARIN SODIUM 196 173 13 18
SIMVASTATIN 186 160 14 6
AZITHROMYCIN 182 138 15 39
TRAZODONE HCL 178 143 16 36
RANITIDINE HCL 149 119 17 27
AMLODIPINE BESYLATE-BENAZEPRIL 138 138 18 44
METOPROLOL SUCCINATE 129 101 19 14
PRAVASTATIN SODIUM 127 111 20 11
CLONIDINE HCL 125 82 21 32
GLIPIZIDE 115 63 22 81
DIOVAN 110 110 23 37
CEPHALEXIN 107 79 24 84
MELOXICAM 105 81 25 13
ATENOLOL 104 74 26 25
ATORVASTATIN CALCIUM 99 84 27 20
TRAMADOL HCL 98 88 28 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 70 28 16
DIGOXIN 94 70 30 52
CARVEDILOL 93 73 31 15
POLYETHYLENE GLYCOL 3350 89 88 32 56
INDAPAMIDE 88 70 33 188
CIPROFLOXACIN HCL 87 60 34 45
NEXIUM 86 69 35 23
DILTIAZEM 24HR CD 76 54 36 152
GLIMEPIRIDE 71 59 37 30
GABAPENTIN 68 64 38 10
TAMSULOSIN HCL 68 57 38 38
LYRICA 67 44 40 57
CITALOPRAM HBR 67 40 40 17
PANTOPRAZOLE SODIUM 66 63 42 42
METOPROLOL TARTRATE 65 50 43 22
BISOPROLOL-HYDROCHLOROTHIAZIDE 64 48 44 140
CRESTOR 63 62 45 29
CEFPROZIL 63 50 45 202
NOVOLIN 70-30 62 40 47 181
ALLOPURINOL 61 61 48 31
FINASTERIDE 57 57 49 197
QUETIAPINE FUMARATE 55 54 50 72
PROAIR HFA 54 22 51 79
ESTRADIOL 53 24 R 52 109
GLIPIZIDE ER 53 50 52 103
LANTUS 51 44 54 55
BENAZEPRIL HCL 51 44 54 58
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.